Table 2.
Unadjusted OR (95% CI) | P-value | Adjusted OR† (95% CI) | P-value† | |
---|---|---|---|---|
Age, years | 1.09 [1.07–1.11] | < 0.001 | 1.09 [1.07–1.11] | < 0.001 |
Sex, male | 1.05 [0.79–1.39] | 0.748 | 0.98 [0.73–1.31] | 0.872 |
Body mass index, kg/m2 | 1.02 [0.98–1.07] | 0.305 | 1.01 [0.96–1.06] | 0.835 |
Use of antihypertensives | 1.89 [1.37–2.60] | < 0.001 | 1.41 [1.00–1.97] | 0.048 |
Use of antiplatelet agents | 1.63 [1.05–2.54] | 0.031 | 1.01 [0.63–1.62] | 0.959 |
hs-CRP, mg/dL* | 1.13 [1.03–1.24] | 0.008 | 1.07 [0.97–1.18] | 0.170 |
TyG index | 1.44 [1.13–1.82] | 0.003 | 1.39 [1.06–1.81] | 0.017 |
hs-CRP: high-sensitivity C-reactive protein; TyG index: triglyceride-glucose index
*These variables were transformed into a log scale
†Adjusted with P < 0.05 in univariate analysis (age, use of antihypertensives, use of antiplatelet agents, hs-CRP, and TyG index) and sex and BMI